JUBILANT PHARMOVA
Back to Balance Sheet
|
JUBILANT PHARMOVA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹15,266 Cr | ₹12,499 Cr | ₹11,316 Cr | ₹10,929 Cr | ₹9,830 Cr |
What is the latest Total Liabilities ratio of JUBILANT PHARMOVA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹15,266 Cr |
| Mar2025 | ₹12,499 Cr |
| Mar2024 | ₹11,316 Cr |
| Mar2023 | ₹10,929 Cr |
| Mar2022 | ₹9,830 Cr |
How is Total Liabilities of JUBILANT PHARMOVA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹15,266 Cr | 22.13 | |
| Mar2025 | ₹12,499 Cr | 10.46 | |
| Mar2024 | ₹11,316 Cr | 3.54 | |
| Mar2023 | ₹10,929 Cr | 11.19 | |
| Mar2022 | ₹9,830 Cr | - | |
Compare Total Liabilities of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹14,051.1 Cr | -2.3% | -8.2% | -18.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -2.3% |
-8.2% |
-18.7% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses